Assignee
GENENTECH INC
US2,896 patents
Top patents by PatentIndex Score
US7862817B2Jan 4, 2011
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
GENENTECH INC126 citations99
US7695936B2Apr 13, 2010
Knobs and holes heteromeric polypeptides
GENENTECH INC817 citations99
US7666413B2Feb 23, 2010
Method of reducing viscosity of high concentration protein formulations
GENENTECH INC103 citations99
US7642228B2Jan 5, 2010
Method for making heteromultimeric polypeptides
GENENTECH INC404 citations99
US7560111B2Jul 14, 2009
HER2 antibody composition
GENENTECH INC122 citations99
US7537931B2May 26, 2009
Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodies
GENENTECH INC83 citations99
US7501122B2Mar 10, 2009
Treatment with anti-ErbB2 antibody combinations
GENENTECH INC76 citations99
US7498030B2Mar 3, 2009
Treatment with anti-ErbB2 antibodies and anti-hormonal compounds
GENENTECH INC69 citations99
US7485302B2Feb 3, 2009
Treatment with anti-ErbB2 antibodies and chemotherapeutic agents
GENENTECH INC109 citations99
US7416727B2Aug 26, 2008
Polypeptide variants with altered effector function
GENENTECH INC89 citations99
US7371826B2May 13, 2008
Polypeptide variants with altered effector function
GENENTECH INC1,099 citations99
US7335742B2Feb 26, 2008
Polypeptide variants with altered effector function
GENENTECH INC167 citations99
US7332581B2Feb 19, 2008
Polypeptide variants with altered effector function
GENENTECH INC1,197 citations99
US7183387B1Feb 27, 2007
Polypeptide variants with altered effector function
GENENTECH INC223 citations99
US7169901B2Jan 30, 2007
Anti-VEGF antibodies
GENENTECH INC160 citations99
US7122637B2Oct 17, 2006
Polypeptide variants with altered effector function
GENENTECH INC188 citations99
US7060269B1Jun 13, 2006
Anti-VEGF antibodies
GENENTECH INC342 citations99
US6998253B1Feb 14, 2006
Altered polypeptides with increased half-life
GENENTECH INC250 citations99
US6949245B1Sep 27, 2005
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
GENENTECH INC317 citations99
US6916648B2Jul 12, 2005
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC90 citations99
US6884879B1Apr 26, 2005
Anti-VEGF antibodies
GENENTECH INC623 citations99
US6875432B2Apr 5, 2005
Reduced-viscosity concentrated protein formulations
GENENTECH INC316 citations99
US6800738B1Oct 5, 2004
Method for making humanized antibodies
GENENTECH INC274 citations99
US6737056B1May 18, 2004
Polypeptide variants with altered effector function
GENENTECH INC3,376 citations99
US6719971B1Apr 13, 2004
Method for making humanized antibodies
GENENTECH INC393 citations99
US6639055B1Oct 28, 2003
Method for making humanized antibodies
GENENTECH INC523 citations99
US6635468B2Oct 21, 2003
Secreted and transmembrane polypeptides and nucleic acids encoding the same
GENENTECH INC92 citations99
US6582959B2Jun 24, 2003
Antibodies to vascular endothelial cell growth factor
GENENTECH INC283 citations99
US6451561B1Sep 17, 2002
Growth hormone variants
GENENTECH INC96 citations99
US6451764B1Sep 17, 2002
VEGF-related protein
GENENTECH INC143 citations99
US6407213B1Jun 18, 2002
Method for making humanized antibodies
GENENTECH INC2,158 citations99
US6399063B1Jun 4, 2002
Monoclonal antibodies directed to the HER2 receptor
GENENTECH INC282 citations99
US6387371B1May 14, 2002
Monoclonal antibodies directed to the HER2 receptor
GENENTECH INC272 citations99
US6342369B1Jan 29, 2002
Apo-2-receptor
GENENTECH INC127 citations99
US6172213B1Jan 9, 2001
Anti-IgE antibodies and method of improving polypeptides
GENENTECH INC155 citations99
US6165464ADec 26, 2000
Monoclonal antibodies directed to the HER2 receptor
GENENTECH INC363 citations99
US6153189ANov 28, 2000
Human TRK receptors and neurotrophic factor inhibitors
GENENTECH INC165 citations99
US6121022ASep 19, 2000
Altered polypeptides with increased half-life
GENENTECH INC1,223 citations99
US6096871AAug 1, 2000
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
GENENTECH INC290 citations99
US6054297AApr 25, 2000
Humanized antibodies and methods for making them
GENENTECH INC2,266 citations99
US6037453AMar 14, 2000
Immunoglobulin variants
GENENTECH INC180 citations99
US6037454AMar 14, 2000
Humanized anti-CD11a antibodies
GENENTECH INC183 citations99
US6027927AFeb 22, 2000
Human trk receptors and neurotrophic factor inhibitors
GENENTECH INC137 citations99
US6022711AFeb 8, 2000
Human growth hormone variants having enhanced affinity for human growth hormone receptor at site 1
GENENTECH INC100 citations99
US6013478AJan 11, 2000
Method for identifying active domains and amino acid residues in polypeptides and hormone variants
GENENTECH INC184 citations99
US5994511ANov 30, 1999
Anti-IgE antibodies and methods of improving polypeptides
GENENTECH INC210 citations99
US5910574AJun 8, 1999
Human trk receptors and neurotrophic factor inhibitors
GENENTECH INC140 citations99
US5877016AMar 2, 1999
Human trk receptors and neurotrophic factor inhibitors
GENENTECH INC190 citations99
US5869046AFeb 9, 1999
Altered polypeptides with increased half-life
GENENTECH INC2,474 citations99
US5844092ADec 1, 1998
Human TRK receptors and neurotrophic factor inhibitors
GENENTECH INC219 citations99
Showing the top 50 of 2,896 patents by PatentIndex Score.